HER-1 and HER-2 Targeting in Cancer
 

www.cancernetwork.com/her2/october_2005/2.html

A review of the biology and pharmacology of Her inhibitors.

Really interesting
 

Thanks for that. It was really good on laying out where the science was heading for Her2, especially her2 ER+. It was frustrating, however, to see how little progress there has been in targeting her1 by itself, since the triple negatives could sure use some help.

Thanks
 

Okay, I don't understand everything I read, but thanks for giving me something worth reading to chew on.

A.A.